Landmark CAR-T cancer study published in the New England Journal of Medicine

(Loyola University Health System) Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news